Literature DB >> 10030385

Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits.

D Behr1, A Rupin, J N Fabiani, T J Verbeuren.   

Abstract

The expression of inducible nitric oxide synthase (iNOS) as well as its functional activity has recently been reported in atherosclerotic lesions. The aim of the present study was to evaluate the expression of iNOS in various arteries of rabbits fed a long-term but low-level cholesterol-enriched diet which promotes different types of atherosclerotic lesions resembling human diseased vessels. No iNOS expression was revealed in arteries from control rabbits and in fatty streaks found in carotid and femoral arteries from hypercholesterolemic rabbits. In transitional lesions from the thoracic and abdominal aortas, the coronary and pulmonary arteries, a punctiform iNOS staining was detected in the intima. When lesions were more advanced, iNOS expression was found more intense and diffuse and localized in the subendothelial layer as well as in the media. Smooth muscle cell accumulation in intimal layers of the arteries is a marker of the degree of evolution of the atherosclerotic lesion; since we found a correlation between the smooth muscle cell infiltration in the intima and the iNOS expression in the intima and the subendothelial layer, our results suggest a link between the severity of the lesion and the iNOS expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030385     DOI: 10.1016/s0021-9150(98)00254-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment.

Authors:  J W Knowles; R L Reddick; J C Jennette; E G Shesely; O Smithies; N Maeda
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Cutaneous venous dysfunction studied in vivo in the LPS-treated rabbit: implication of NO in saphenous vein hyporeactivity.

Authors:  Christine Vayssettes-Courchay; Marta Chataigneau; Cedric Protin; Christophe Ragonnet; Tony J Verbeuren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-02       Impact factor: 3.000

Review 3.  Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.

Authors:  Louis J Ignarro; Claudio Napoli
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

Review 4.  Role of farnesoid X receptor in inflammation and resolution.

Authors:  Firdose Begum Shaik; Durbaka V R Prasad; Venkata Ramireddy Narala
Journal:  Inflamm Res       Date:  2014-11-07       Impact factor: 4.575

5.  Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production.

Authors:  Ruba S Deeb; Hao Shen; Caryn Gamss; Tatyana Gavrilova; Barbara D Summers; Rosemary Kraemer; Gang Hao; Steven S Gross; Muriel Lainé; Nobuyo Maeda; David P Hajjar; Rita K Upmacis
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

Review 6.  Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.

Authors:  Louis J Ignarro; Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

7.  Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis.

Authors:  Volker O Melichar; Delphine Behr-Roussel; Ulrike Zabel; L Otto Uttenthal; José Rodrigo; Alain Rupin; Tony J Verbeuren; Arun Kumar H S; Harald H H W Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

8.  Daming capsule restores endothelial dysfunction induced by high-fat diet.

Authors:  Rong Zhang; Huifang Niu; Ning Wang; Lihua Sun; Yi Xu; Ruibo Zhao; Xiang Ban; Yao Yu; Baofeng Yang; Jing Ai
Journal:  BMC Complement Altern Med       Date:  2012-03-24       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.